FDA.reportPublic FDA data

Meclizine Hydrochloride

Manufacturer
Walgreen Company
Effective date
2025-03-11
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
full-release
Hydrated at
2026-06-01 00:57:02

Label at a glance#

ProductMeclizine Hydrochloride
Active ingredientMECLIZINE HYDROCHLORIDE
Label structure10 sections

Indications and uses

for prevention and treatment of these symptoms associated with motion sickness: nausea vomiting dizziness

Dosage and administration

• to prevent motion sickness take first dose ½ hour to 1 hour before activity • to treat motion sickness, take at first sign of symptoms • adults and children 12 years and over : 1 to 2 tablets once daily, or as directed by a doctor

Label contents#

Full prescribing information#

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

Active ingredient (in each tablet)
Meclizine HCl 25 mg

OTC - PURPOSE SECTION

Purpose
Antiemetic

Uses

INDICATIONS & USAGE SECTION

for prevention and treatment of these symptoms associated with motion sickness:

  • nausea
  • vomiting
  • dizziness

WARNINGS SECTION

Do not give to children under 12 years of age unless directed by a doctor.

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have

  • a breathing problem such as emphysema or chronic bronchitis
  • glaucoma
  • trouble urinating due to an enlarged prostate gland

OTC - ASK DOCTOR/PHARMACIST SECTION

Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers.

OTC - WHEN USING SECTION

When using this product

  • drowsiness may occur
  • avoid alcoholic drinks
  • alcohol, sedatives, and tranquilizers may increase drowsiness
  • be careful when driving a motor vehicle or operating machinery

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a doctor before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

OVERDOSAGE SECTION

In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) immediately.

Directions

DOSAGE & ADMINISTRATION SECTION

• to prevent motion sickness take first dose ½ hour to 1 hour before activity
• to treat motion sickness, take at first sign of symptoms
• adults and children 12 years and over: 1 to 2 tablets once daily, or as directed by a doctor

Other information

OTHER SAFETY INFORMATION


store in a dry place at 15° – 30°C (59° – 86°F)

INACTIVE INGREDIENT SECTION

croscarmellose sodium, crospovidone, FD&C red #40 lake, french vanilla flavor, lactose, magnesium stearate, raspberry flavor, silica, sodium saccharin, stearic acid.

OTC - QUESTIONS SECTION

1-800-925-4733

SPL UNCLASSIFIED SECTION

Tamper Evident: Do not use if outer carton is open or if blister is open or torn.

Important: Keep carton for future reference.

†Our pharmacists recommend the Walgreens brand. We invite you to compare to national brands.
††This product is not manufactured or distributed by MedTech Products Inc., owner of the registered trademark Dramamine®.

DISTRIBUTED BY: WALGREEN CO.
DEERFIELD, IL 60015
100% SATISFACTION GUARANTEED
walgreens.com ©2024 Walgreen Co.
Manufactured and packaged in USA using domestic and imported ingredients

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 0363-5172-07

Compare to the active ingredient in Dramamine® All Day Less Drowsy††

Motion Sickness Relief

MECLIZINE HCl 25 mg / ANTIEMETIC

All Day Relief

Less Drowsy Formula

Chewable

Helps prevent nausea, dizziness & vomiting due to motion sickness

All-day relief of motion sickness

For adults & children 12 years & up

Raspberry flavor

12 Chewable Tablets

Walgreen LabelWalgreen Label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
995632meclizine HCl 25 MG Chewable TabletPSN3
995632meclizine hydrochloride 25 MG Chewable TabletSCD3

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
MECLIZINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
ac6963c4-31c6-325f-ee58-83a0a06597adProduct name520221206

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0363-5172-07Meclizine Hydrochloride1 in 1 CARTONTABLET, CHEWABLE13
0363-5172-07Meclizine Hydrochloride12 in 1 BLISTER PACKTABLET, CHEWABLE123

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0363-5172MECLIZINE HYDROCHLORIDE TABLET, CHEWABLE [WALGREEN COMPANY]3Current NDC, 2 package rows20250313_ecf8d05e-0e77-f3e8-e053-2a95a90a6604.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0363-51720363-5172-07

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Name, UNII, Kind table
NameUNIIKind
SILICON DIOXIDEETJ7Z6XBU4IACT
STEARIC ACID4ELV7Z65APIACT
VANILLAQ74T35078HIACT
LACTOSE MONOHYDRATEEWQ57Q8I5XIACT
MAGNESIUM STEARATE70097M6I30IACT
RASPBERRY4N14V5R27WIACT
CROSCARMELLOSE SODIUMM28OL1HH48IACT
MECLIZINE HYDROCHLORIDEHDP7W44CIOACTIB
CROSPOVIDONE2S7830E561IACT
SACCHARIN SODIUMSB8ZUX40TYIACT
FD&C RED NO. 40WZB9127XOAIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Meclizine HydrochlorideMECLIZINE HYDROCHLORIDEWalgreen Companyecf8d05e-0e77-f3e8-e053-2a95a90a66042025-03-11WarningsExact identifier
ndc (package): 0363-5172-07
ndc (product): 0363-5172
ndc11 (package): 00363517207
spl id: 30139dc7-2c78-271f-e063-6294a90aa001
spl set id: ecf8d05e-0e77-f3e8-e053-2a95a90a6604

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.